Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain
- PMID: 9348546
- DOI: 10.1016/S0893-133X(97)00071-7
Autoradiographic localization of CRF1 and CRF2 binding sites in adult rat brain
Abstract
The regional distribution of corticotropin-releasing factor1 (CRF1) and CRF2 binding sites was assessed autoradiographically in adult rat brain. The differential pharmacological profiles of the CRF1 and CRF2 receptor subtypes were used for the discrimination of the CRF1 and CRF2 receptor subtypes in rat brain. Pharmacological characterization at the human CRF1 receptor subtype, expressed in baculovirus-infected Sf9 cells, showed high affinity binding (Ki < or = 10.0 nM) for the peptide agonists sauvagine, urotensin I, rat/human CRF, and ovine CRF. Pharmacological characterization at the rat CRF2 receptor subtype expressed in CHO cells showed a rank order affinity for the peptide agonists such that sauvagine, urotensin I and rat/human CRF showed high affinity binding whereas ovine CRF had a Ki value of 300 nM. Based on this differential binding affinity for ovine CRF, [125I]sauvagine binding in the presence of increasing concentrations of ovine CRF was used to discriminate CRF1 from CRF2 receptor subtypes in rat brain. The CRF1 receptor subtype was found to be localized to various regions of the cerebellum, as well as to several cortical areas. The CRF2 receptor subtype was shown to be localized to the lateral septal nucleus, entorhinal cortex, and to amygdaloid and hypothalamic regions. The present autoradiographic findings provide evidence that each subtype has a distinct regional distribution, thus strengthening the suggestion that CRF1 and CRF2 receptors serve different roles in mediating CRF function. Such data suggest that the development of CRF receptor subtype selective antagonists should help to delineate the role of CRF1 and CRF2 receptor subtypes in central nervous system function.
Similar articles
-
125I-Tyro-sauvagine: a novel high affinity radioligand for the pharmacological and biochemical study of human corticotropin-releasing factor 2 alpha receptors.Mol Pharmacol. 1996 Sep;50(3):679-86. Mol Pharmacol. 1996. PMID: 8794910
-
Autoradiographic and in situ hybridization localization of corticotropin-releasing factor 1 and 2 receptors in nonhuman primate brain.J Comp Neurol. 1999 Jun 7;408(3):365-77. J Comp Neurol. 1999. PMID: 10340512
-
Human CRF2 alpha and beta splice variants: pharmacological characterization using radioligand binding and a luciferase gene expression assay.Neuropharmacology. 1999 Mar;38(3):441-8. doi: 10.1016/s0028-3908(98)00201-9. Neuropharmacology. 1999. PMID: 10219982
-
Recent advances with the CRF1 receptor: design of small molecule inhibitors, receptor subtypes and clinical indications.Curr Pharm Des. 1999 May;5(5):289-315. Curr Pharm Des. 1999. PMID: 10213797 Review.
-
Cortagine: behavioral and autonomic function of the selective CRF receptor subtype 1 agonist.CNS Drug Rev. 2007 Winter;13(4):423-43. doi: 10.1111/j.1527-3458.2007.00027.x. CNS Drug Rev. 2007. PMID: 18078427 Free PMC article. Review.
Cited by
-
Angst and the amygdala.Dialogues Clin Neurosci. 2006;8(4):407-16. doi: 10.31887/DCNS.2006.8.4/jschulkin. Dialogues Clin Neurosci. 2006. PMID: 17290799 Free PMC article. Review.
-
Alcohol-preferring rats show decreased corticotropin-releasing hormone-2 receptor expression and differences in HPA activation compared to alcohol-nonpreferring rats.Alcohol Clin Exp Res. 2014 May;38(5):1275-83. doi: 10.1111/acer.12379. Epub 2014 Mar 10. Alcohol Clin Exp Res. 2014. PMID: 24611993 Free PMC article.
-
Urocortin 3 elevates cytosolic calcium in nucleus ambiguus neurons.J Neurochem. 2012 Sep;122(6):1129-36. doi: 10.1111/j.1471-4159.2012.07869.x. Epub 2012 Aug 3. J Neurochem. 2012. PMID: 22774996 Free PMC article.
-
Regulation of serotonin release in the lateral septum and striatum by corticotropin-releasing factor.J Neurosci. 2001 Apr 15;21(8):2833-41. doi: 10.1523/JNEUROSCI.21-08-02833.2001. J Neurosci. 2001. PMID: 11306635 Free PMC article.
-
Emerging targets for addiction neuropharmacology: From mechanisms to therapeutics.Prog Brain Res. 2016;224:251-84. doi: 10.1016/bs.pbr.2015.07.018. Epub 2015 Nov 26. Prog Brain Res. 2016. PMID: 26822362 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources